VIATIM

This brand name is authorized in Austria, Ireland, United Kingdom

Active ingredients

The drug VIATIM contains a combination of these active pharmaceutical ingredients (APIs):

1 Hepatitis A, inactivated vaccine UNII G54MT8V18G - HEPATITIS A VIRUS

Inactivated virus of a strain which was originally derived by further serial passage of a proven attenuated strain. The virus is grown, harvested, highly purified, formalin inactivated, and then adsorbed onto amorphous aluminum hydroxyphosphate sulphate. Read about Hepatitis A, inactivated vaccine

2 Typhoid purified polysaccharide antigen UNII 7194H8W3KT - SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN

Read about Typhoid purified polysaccharide antigen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07AP03	Typhoid, purified polysaccharide antigen	J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AP Typhoid vaccines
Discover more medicines within J07AP03
J07BC02	Hepatitis A, inactivated, whole virus	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BC Hepatitis vaccines
Discover more medicines within J07BC02
J07CA10	Typhoid-hepatitis A	J Antiinfectives for systemic use → J07 Vaccines → J07C Bacterial and viral vaccines, combined → J07CA Bacterial and viral vaccines, combined
Discover more medicines within J07CA10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 112360